C M Kühlbrey1, N Samiei1, O Sick1, F Makowiec1, U T Hopt1, U A Wittel2. 1. Clinic for General and Visceral Surgery, Department of Surgery, University of Freiburg, Freiburg, Germany. 2. Clinic for General and Visceral Surgery, Department of Surgery, University of Freiburg, Freiburg, Germany. uwe.wittel@uniklinik-freiburg.de.
Abstract
BACKGROUND: Morbidity after pancreas resection is still high with postoperative pancreatic fistulas (POPF) being the most frequent complication. However, exocrine insufficiency seems to protect from POPF. In clinical practice, patients showing increased postoperative systemic amylase concentrations appear to frequently develop POPF. We therefore retrospectively examined the occurrence of systemic amylase increase after pancreas resections and its association with the clinical course. PATIENTS AND METHODS: Perioperative data from 739 consecutive pancreas resections were assessed in a prospectively maintained SPSS database. Serum and drain amylase concentrations were determined by routine clinical chemistry. POPFs were graded into A-C according to ISGPF definitions. RESULTS: In patients with reduced serum amylase (n = 89) on day 1 after pancreatoduodenectomy, clinically relevant POPFs were not observed. In patients with normal serum amylase concentrations, clinically relevant POPFs occurred in 9 %, while in 39 % of the patients with more than three times elevated amylase concentrations, a clinically relevant postoperative fistula was observed (p < 0.001). Systemic hyperamylasemia detected on postoperative day 1 after pancreatoduodenectomy was further a good predictor for clinically relevant POPFs (AUROC = 0.797, p < 0.001). CONCLUSION: Patients with a high risk for developing clinically relevant POPFs can be identified on the first postoperative day by determining serum amylase.
BACKGROUND: Morbidity after pancreas resection is still high with postoperative pancreatic fistulas (POPF) being the most frequent complication. However, exocrine insufficiency seems to protect from POPF. In clinical practice, patients showing increased postoperative systemic amylase concentrations appear to frequently develop POPF. We therefore retrospectively examined the occurrence of systemic amylase increase after pancreas resections and its association with the clinical course. PATIENTS AND METHODS: Perioperative data from 739 consecutive pancreas resections were assessed in a prospectively maintained SPSS database. Serum and drain amylase concentrations were determined by routine clinical chemistry. POPFs were graded into A-C according to ISGPF definitions. RESULTS: In patients with reduced serum amylase (n = 89) on day 1 after pancreatoduodenectomy, clinically relevant POPFs were not observed. In patients with normal serum amylase concentrations, clinically relevant POPFs occurred in 9 %, while in 39 % of the patients with more than three times elevated amylase concentrations, a clinically relevant postoperative fistula was observed (p < 0.001). Systemic hyperamylasemia detected on postoperative day 1 after pancreatoduodenectomy was further a good predictor for clinically relevant POPFs (AUROC = 0.797, p < 0.001). CONCLUSION:Patients with a high risk for developing clinically relevant POPFs can be identified on the first postoperative day by determining serum amylase.
Authors: Matthias Hassenpflug; Werner Hartwig; Oliver Strobel; Ulf Hinz; Thilo Hackert; Stefan Fritz; Markus W Büchler; Jens Werner Journal: Surgery Date: 2012-07-18 Impact factor: 3.982
Authors: Moritz N Wente; Shailesh V Shrikhande; Michael W Müller; Markus K Diener; Christoph M Seiler; Helmut Friess; Markus W Büchler Journal: Am J Surg Date: 2007-02 Impact factor: 2.565
Authors: Markus K Diener; Christoph M Seiler; Inga Rossion; Jörg Kleeff; Matthias Glanemann; Giovanni Butturini; Ales Tomazic; Christiane J Bruns; Olivier R C Busch; Stefan Farkas; Orlin Belyaev; John P Neoptolemos; Christopher Halloran; Tobias Keck; Marco Niedergethmann; Klaus Gellert; Helmut Witzigmann; Otto Kollmar; Peter Langer; Ulrich Steger; Jens Neudecker; Frederik Berrevoet; Silke Ganzera; Markus M Heiss; Steffen P Luntz; Thomas Bruckner; Meinhard Kieser; Markus W Büchler Journal: Lancet Date: 2011-04-30 Impact factor: 79.321
Authors: Cristina Ridolfi; Maria Rachele Angiolini; Francesca Gavazzi; Paola Spaggiari; Maria Carla Tinti; Fara Uccelli; Marco Madonini; Marco Montorsi; Alessandro Zerbi Journal: Biomed Res Int Date: 2014-05-13 Impact factor: 3.411